Taxus liberte

Manufactured by Boston Scientific

Sourced in New Zealand, United States

The Taxus™ Liberte™ is a medical device designed for use in percutaneous coronary intervention procedures. It is a drug-eluting stent system that features a flexible, low-profile stent and a polymer-based drug coating.

Automatically generated - may contain errors

Lab products found in correlation

Xience 5, by Abbott (1 mentions)

2 protocols using taxus liberte

Evaluation of Paclitaxel-Coated Balloon Catheters

Check if the same lab product or an alternative is used in the 5 most similar protocols

The PCBs used in these series of studies were Lutonix drug coated balloon catheter (Bard Lutonix, New Hope, MN). This technology comprises a standard peripheral angioplasty balloon catheter coated with a proprietary paclitaxel (2 µg/mm²⁾ and excipients (polysorbate and sorbitol) on the surface of the balloon. The control balloons used in this study (2.5, 3.0, or 3.5 × 12 mm) were of identical material and manufactured by the same vendor (Clearstream, Bard Peripheral Vascular, Tempe, AZ).
Paclitaxel‐eluting stent (PES), Taxus™ Liberte™, Boston Scientific, Marlborough, Massachusetts; Everolimus Eluting Stent, Xience‐Pro, and Vision Multi‐Link 8, Abbott Vascular, Chicago, Illinois; and Zotarolimus Eluting Stent, Resolute Integrity, Medtronic Vascular, Minneapolis, Minnesota. All stents were 2.5–3.5 mm × 8 mm.

Li Y., Tellez A., Rousselle S.D., Dillon K.N., Garza J.A., Barry C, & Granada J.F. (2015). Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model. Catheterization and Cardiovascular Interventions, 88(1), 89-98.

+ Open protocol

+ Expand

Coronary Artery Disease: Stent Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols

A total of 96 patients with de novo coronary artery lesions, who underwent elective PCI at Sanggye Paik Hospital, Seoul, Korea, were retrospectively reviewed for this study. Patients with re-stenotic coronary lesion, multiple stent deployment in a single coronary artery, reference diameter of estimated coronary lesion smaller than 2.5 mm, and inadequate angiographic image quality were excluded. In total 112 de novo lesions from enrolled patients were treated with one of the following four different types of stent: 25 received a Taxus Liberte (Boston Scientific, USA), 30 a Cypher (Cordis-Johnson and Johnson, USA), 27 an Endeavor Resolute (Medtonic, USA), and 30 a Xience V (Abbott Vascular, USA).

Kim B.G., Cho S.W., Kim D.H., Kim J.H., Byun Y.S., Goh C.W., Rhee K.J., Lee B.K, & Kim B.O. (2015). Stent length is a contributing factor of suboptimal stent expansion in drug-eluting stents. Kardiologia polska, 73(8).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!